MDPI and ACS Style
Timpanaro, A.; Piccand, C.; Uldry, A.-C.; Bode, P.K.; Dzhumashev, D.; Sala, R.; Heller, M.; Rössler, J.; Bernasconi, M.
Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. Int. J. Mol. Sci. 2023, 24, 2601.
https://doi.org/10.3390/ijms24032601
AMA Style
Timpanaro A, Piccand C, Uldry A-C, Bode PK, Dzhumashev D, Sala R, Heller M, Rössler J, Bernasconi M.
Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. International Journal of Molecular Sciences. 2023; 24(3):2601.
https://doi.org/10.3390/ijms24032601
Chicago/Turabian Style
Timpanaro, Andrea, Caroline Piccand, Anne-Christine Uldry, Peter Karl Bode, Dzhangar Dzhumashev, Rita Sala, Manfred Heller, Jochen Rössler, and Michele Bernasconi.
2023. "Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma" International Journal of Molecular Sciences 24, no. 3: 2601.
https://doi.org/10.3390/ijms24032601